JACOBS LEVY EQUITY MANAGEMENT, INC

Position in NRIX — Nurix Therapeutics, Inc.

CIK 884414 FLORHAM PARK, NJ

Position in NRIX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$8,821,008

-$801,702 QoQ

Shares Held

363,603

-41.4% QoQ

Ownership

0.350%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#47

of 210 holders

Holding Since

Sep 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $741,570,791 across 81 Biotechnology names. NRIX ranks #18 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	256,503	$159,939,880
2	RARE	Ultragenyx Pharmaceutical Inc.	2,939,719	$98,157,217
3	INCY	Incyte Corp	731,774	$82,953,900
4	CORT	Corcept Therapeutics Inc	695,532	$60,476,507
5	HALO	Halozyme Therapeutics, Inc.	322,377	$25,232,447
6	EXEL	Exelixis, Inc.	415,650	$22,615,516
7	AUPH	Aurinia Pharmaceuticals Inc.	1,231,516	$20,898,826
8	ALNY	Alnylam Pharmaceuticals, Inc.	60,986	$18,358,615

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,821,008	363,603	-41.4%	Shares	Sole	2026-08-14
2026-03-31	$9,622,710	620,820	-15.6%	Shares	Sole	2026-05-15
2025-12-31	$13,946,250	735,174	+1576.1%	Shares	Sole	2026-02-13
2025-09-30	$405,294	43,863	-80.9%	Shares	Sole	2025-11-17
2024-12-31	$4,321,311	229,369	+2.0%	Shares	Sole	2025-02-14
2024-06-30	$4,693,829	224,908	-48.2%	Shares	Sole	2024-08-14
2024-03-31	$6,385,871	434,413	+73.5%	Shares	Sole	2024-05-15
2023-12-31	$2,583,374	250,327	+1.3%	Shares	Sole	2024-02-14
2023-09-30	$1,942,048	247,080	+426.9%	Shares	Sole	2023-11-17
2023-06-30	$468,491	46,896	-69.9%	Shares	Sole	2023-08-14
2023-03-31	$1,384,782	155,944	-26.8%	Shares	Sole	2023-05-15
2022-12-31	$2,339,629	213,081	+1558.1%	Shares	Sole	2023-02-14
2022-09-30	$167,448	12,851	—	Shares	Sole	2022-11-15
No filing history on record for this holder in this stock.